ArticleCureus2025
Acute Rhabdomyolysis as a Rare Manifestation of Hypothyroidism: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unexpected Cancellation of Radioactive Iodine Treatment after Thyroid Hormone Withdrawal: Lessons from a Case Series.Endocrinology and metabolism (Seoul, Korea) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid myopathy is often subtle, but massive rhabdomyolysis secondary to hypothyroidism is an exceptional phenomenon, with approximately 30 to 40 cases reported in the medical literature to date. We report a case of rhabdomyolysis secondary to profound hypothyroidism in the absence of any precipitating factor. This is a 56-year-old woman who underwent a right mastectomy six years ago for breast cancer and received adjuvant chemotherapy for two months followed by four weeks of radiotherapy. She has been on letrozole 2.5 mg daily for six years. Over the past three months, she has developed physical and psychological asthenia, constipation, muscle fatigue, and myalgia, predominantly in the proximal muscles of the four limbs. Clinical examination found signs of myxedema infiltration and signs of hypometabolism. The laboratory assessment revealed elevated levels of total creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and transaminases (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)). The thyroid function test indicated profound hypothyroidism, with a significantly elevated ultrasensitive thyroid-stimulating hormone (TSHus) level. Anti-thyroperoxidase antibodies were negative, as were anti-thyroglobulin antibodies. Cervical ultrasound revealed an atrophic thyroid and loss of the musculoparenchymal gradient, suggestive of thyroiditis. Computed tomography brain was normal. The diagnosis was made based on her clinical presentation and laboratory tests. The outcome was marked, after treatment, by good clinical and biological improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.